Department of General Surgery, Hebei Key Laboratory of Colorectal Cancer Precision Diagnosis and Treatment, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Department of Emergency Medicine, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Aging (Albany NY). 2021 Feb 1;13(4):5506-5524. doi: 10.18632/aging.202479.
In this study, we used the ESTIMATE algorithm to analyze clinical data and transcriptome profiles of 1635 colorectal cancer (CRC) samples from the Gene Expression Omnibus and The Cancer Genome Atlas databases and identify prognostic immune-related genes (IRGs). We identified 941 differentially expressed (4 downregulated and 937 upregulated) genes by comparing samples with high and low immune, stromal scores and tumor purity. LASSO Cox regression analyses showed that the risk score based on a ten-IRG signature was an independent prognostic factor in CRC. The nomogram with pathological stages (TNM) and the ten-IRG signature showed a C-index of 0.769 (95% CI, 0.717-0.821), and area under ROC curve values of 0.788, 0.782 and 0.789 for 1-, 3-, and 5-year OS, respectively. TIMER database analysis showed positive correlation between the ten prognostic IRGs and the levels of tumor-infiltrated immune cells, including CD4 and CD8 T cells, macrophages, neutrophils, and dendritic cells. These findings demonstrate that this novel ten-IRG signature correlates with the pathological stages and the levels of multiple tumor-infiltrated immune cell types. This makes the ten-IRG signature a potential prognostic factor for CRC patients.
在这项研究中,我们使用 ESTIMATE 算法分析了来自基因表达综合数据库和癌症基因组图谱数据库的 1635 例结直肠癌(CRC)样本的临床数据和转录组谱,并确定了预后免疫相关基因(IRG)。我们通过比较高免疫、基质评分和肿瘤纯度的样本,鉴定了 941 个差异表达的基因(4 个下调和 937 个上调)。LASSO Cox 回归分析表明,基于十个 IRG 特征的风险评分是 CRC 的一个独立预后因素。具有病理分期(TNM)和十个 IRG 特征的列线图显示 C 指数为 0.769(95%CI,0.717-0.821),ROC 曲线下面积值分别为 0.788、0.782 和 0.789,用于 1 年、3 年和 5 年 OS。TIMER 数据库分析显示,十个预后 IRG 与肿瘤浸润免疫细胞的水平呈正相关,包括 CD4 和 CD8 T 细胞、巨噬细胞、中性粒细胞和树突状细胞。这些发现表明,这个新的十个 IRG 特征与病理分期和多种肿瘤浸润免疫细胞类型的水平相关。这使得十个 IRG 特征成为 CRC 患者的一个潜在预后因素。